Trustica is building the continuous monitoring infrastructure that transforms chronic disease management from reactive to preventive.
Indonesia has over 20 million people living with diabetes. Millions more are undiagnosed. The complications are preventable. The cost of inaction is not.
Diabetecs
Approximately 20 million Indonesians are diagnosed with diabetes — and millions more remain undiagnosed due to limited screening access.
In the world
Indonesia ranks among the world’s top 10 countries by total diabetes prevalence, with numbers expected to rise significantly as urbanization accelerates.
Undiagnosed
More than half of all diabetes cases in Indonesia are estimated to be undiagnosed, leaving patients without access to early intervention or monitoring.
Prevalensi
Urban lifestyle changes, aging demographics, and dietary shifts are driving consistent annual growth in Indonesia’s diabetes population
Treating the complications of uncontrolled diabetes costs orders of magnitude more than preventing them.
The Complication Cost Cascade
Kidney Failure (DIALYSIS)
Diabetic nephropathy is the leading cause of end-stage renal disease in Indonesia. Each dialysis patient represents decades of ongoing treatment cost — cost that begins years before the kidney failure is diagnosed.
Cardiovascular Events
Poorly controlled diabetes doubles the risk of stroke and heart disease. Emergency cardiac and neurological care represents some of the most expensive acute interventions in the BPJS system.
Amputation & Wound Care
Diabetic foot complications requiring amputation involve surgical cost, extended hospitalization, rehabilitation, and permanent disability support — all preventable with effective glucose control.
Policy framing: Each avoided dialysis case, cardiac event, or amputation represents not only a direct BPJS cost saving but also a reduction in long-term disability, lost productivity, and family economic disruption — all significant contributors to national social cost.
The question is not whether Indonesia can afford CGM reimbursement. It is whether Indonesia can afford not to
Prevention (CGM Monitoring)
Annual CGM subscription per patient Early intervention cost (medication adjustment) Physician monitoring efficiency gain Quality of life maintained.
BPJS hospitalization avoided
Treatment (Complication Care)
Single dialysis course: 2×/week, lifetime Cardiac bypass or stroke acute care Below-knee amputation + rehabilitation Permanent disability + lost productivity.
Ongoing BPJS chronic care: years to decades
Not a medical device program.
A national health infrastructure.
Trustica connects hospital networks, specialist doctors, patients, and health data — at national scale.
The 4-Component National Platform
From 2,000 patients in Year 1 to 300,000+ by Year 5
A phased national deployment that grows with Indonesia’s healthcare system.
5-Year National Scaling Plan
| Year | Scale | Milestone |
|---|---|---|
| Year 1 | 2,000 patients | Pilot deployment at partner hospitals. Clinical validation and outcome benchmarking. |
| Year 2 | 10,000 patients | Hospital network expansion. Doctor partner program scaling. |
| Year 3 | 50,000 patients | Rapid patient adoption via hospital and digital channels. |
| Year 4 | 150,000 patients | National monitoring ecosystem. Population health data insights available. |
| Year 5 | 300,000+ patients | Regional Southeast Asia expansion potential. Full national chronic disease infrastructure. |
Alignment with National Priorities
BPJS Cost Sustainability
Trustica’s monitoring program directly reduces the BPJS claims burden by preventing the complications that generate the highest per-patient lifetime costs: dialysis, cardiac surgery, and amputation.
Germas Prevention Framework
Continuous monitoring technology aligns directly with the Gerakan Masyarakat Hidup Sehat (GERMAS) framework’s emphasis on disease prevention, early detection, and healthy lifestyle promotion.
Digital Health Acceleration
Trustica’s platform architecture supports Indonesia’s national digital health strategy by building interoperable health data infrastructure that can expand to additional chronic disease categories.
1
Policy Dialogue — Ministerial Briefing
Trustica presents strategic platform overview, national scaling roadmap, and complication cost reduction model to relevant health ministry stakeholders.
2
BPJS Integration Study
Joint analysis of Trustica’s monitoring program against BPJS’s highest-cost diabetic complication categories. Modeling of cost prevention potential at 50,000 and 300,000 patient scale.
3
Regional Pilot Program
Trustica launches a government-endorsed monitoring pilot in a target province or hospital network, generating real-world data on patient outcomes and system cost impact.
4
National Rollout Partnership
Formal collaboration agreement supporting national CGM adoption through hospital networks, BPJS coverage integration, and population health data sharing.
Indonesia’s diabetes epidemic will not wait.
Neither should its national response.
Request a strategic briefing from the Trustica government partnership team.
The 4-Component National Platform
Request Briefing
Propose a Pilot